why choose us

First received: December 15, 2022

Clinical Trial: Patient-Reported Outcomes of Benralizumab in Real-World Use in Severe Eosinophilic Asthma Patients in Taiwan (BEAT)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Asthma

Study Type: OBSERVATIONAL


Official Title: Patient-Reported Outcomes of Benralizumab in Real-World Use in Severe Eosinophilic Asthma Patients in Taiwan

Brief Summary: An open-label, single-arm, non-interventional, prospective, multicenter study involving primary data collection within real-world settings for patients who receive benralizumab for treatment of severe uncontrolled eosinophilic asthma

Read more